| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.54.2.438 |
| P8608 | Fatcat ID | release_hkxljcsnt5hidotopwhlncdhvm |
| P698 | PubMed publication ID | 10668709 |
| P50 | author | Richard Dodel | Q30500712 |
| Martin R. Farlow | Q67212573 | ||
| Jerome Yesavage | Q87854494 | ||
| P2093 | author name string | S M Paul | |
| T Gasser | |||
| Y Du | |||
| R Zimmer | |||
| R Evans | |||
| F Gao | |||
| A Pfefferbaum | |||
| E V Sullivan | |||
| G M Murphy | |||
| B Cordell | |||
| K R Bales | |||
| D Gallagher-Thompson | |||
| L W Thompson | |||
| J R Tinklenberg | |||
| A Hake | |||
| B Eastwood | |||
| B Glazier | |||
| L Alstiel | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 438-442 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Alpha2 macroglobulin and the risk of Alzheimer's disease. | |
| P478 | volume | 54 |
| Q57578011 | Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease |
| Q37120221 | Alzheimer's disease: epidemiology, genetics, and beyond |
| Q53240731 | Association of alpha-2-macroglobulin deletion polymorphism with sporadic Alzheimer's disease in Koreans. |
| Q37936385 | Can cytogenetics explain the possible association between exposure to extreme low-frequency magnetic fields and Alzheimer's disease? |
| Q35146030 | Causative and susceptibility genes for Alzheimer's disease: a review. |
| Q37360205 | Chromosome-12 mapping of late-onset Alzheimer disease among Caribbean Hispanics |
| Q37270464 | Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests. |
| Q34509745 | Dancing in the dark? The status of late-onset Alzheimer's disease genetics |
| Q53353949 | Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease. |
| Q34777681 | Dementia epidemiology |
| Q30308620 | Distinct binding sites in the structure of alpha 2-macroglobulin mediate the interaction with beta-amyloid peptide and growth factors |
| Q35052677 | Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics |
| Q35016050 | Genetic and environmental factors in cancer and neurodegenerative diseases |
| Q37139063 | Genetic aspects of Alzheimer disease |
| Q38579624 | Genetic studies in Alzheimer's disease. |
| Q34134818 | Genetic susceptibility factors for Alzheimer's disease. |
| Q33719164 | Genome-wide data-mining of candidate human splice translational efficiency polymorphisms (STEPs) and an online database |
| Q34153662 | Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease |
| Q38206441 | Influence of Alpha-2-Macroglobulin 5 bp I/D and Ile1000Val polymorphisms on the susceptibility of Alzheimer's disease: a systematic review and meta-analysis of 52 studies |
| Q51955307 | Lack of association of the two polymorphisms in alpha-2 macroglobulin with Alzheimer disease. |
| Q36231849 | Molecular pathology and pathogenesis of inclusion-body myositis |
| Q28194035 | NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line |
| Q35009772 | Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease |
| Q38306892 | Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases. |
| Q34824832 | Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease |
| Q34566566 | Of replications and refutations: the status of Alzheimer's disease genetic research |
| Q34113959 | Part V. Genetic advances and biological markers for Alzheimer's disease |
| Q35009345 | Pharmacogenomics for the treatment of dementia |
| Q73887456 | Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study |
| Q28475611 | Prion protein paralog doppel protein interacts with alpha-2-macroglobulin: a plausible mechanism for doppel-mediated neurodegeneration |
| Q26740342 | Role of ROS and RNS Sources in Physiological and Pathological Conditions |
Search more.